AR

Ankit Raghunath Gupta

Active Director Director DIN 09528083
DIN 09528083 First appointment Mar 2022 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Ankit Raghunath Gupta

Data last updated:

Ankit Raghunath Gupta is a Director at Vol Pharmaceuticals Private Limited (since 2022). The company operates in Food And Beverages.

DIN 09528083
Primary Designation Director
Industry Food And Beverages
First Appointment 07 Mar 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vol Pharmaceuticals Private Limited U24303MH2022PTC377983
Director07 Mar 20222022Active

Board colleagues of Ankit Raghunath Gupta

NameDINCompanyDesignation
Lokesh Ashok Jain09528032Vol Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vol Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ankit Raghunath Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankit Raghunath Gupta

Ankit Raghunath Gupta currently holds 1 directorship: Vol Pharmaceuticals Private Limited (Director, since 07 Mar 2022).

Ankit Raghunath Gupta was first appointed on 07 Mar 2022 as Director at Vol Pharmaceuticals Private Limited.

The current boards of Ankit Raghunath Gupta's companies include Lokesh Ashok Jain (Vol Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available